Evaluation of a xylazine-ketamine hydrochloride combination in the cat.

ABSTRACT Cardiopulmonary function was assessed in healthy cats given a xylazine-ketamine hydrochloride combination intramuscularly. Cardiac output, heart rate, stroke volume and cardiac index were significantly decreased. Systolic, diastolic and mean arterial blood pressure were also significantly decreased. Systemic vascular resistance and central venous pressure were significantly increased. Blood gas values remained stable. In conclusion, significant cardiovascular depression was noted in normal cats given the xylazine-ketamine combination at the dosages listed.


Available from: Dana G Allen, Jun 12, 2015
1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Fenpropathrin, a synthetic pyrethroid widely used as an insecticide, is known to affect locomotion and memory in mammals. It is possible that exposure to pyrethroids may occur in an elderly population where transient ischemic attacks are a higher risk for occurrence with consequent changes in memory and control of movement. Thus, the aim of this study was to determine whether bilateral clamping of carotid arteries (BCCA), a model for ischemia, together with fenpropathrin affected memory in tests such as the passive avoidance task and fresh spatial memory in a Y-maze, as well as movement activity and movement coordination on a rotarod in mice. BCCA together with fenpropathrin significantly reduced latency in a passive avoidance task compared to controls. There were no significant differences among the groups with respect to the Y-maze, movement activity, or movement coordination. In conclusion, fenpropathrin needs to be used with caution in the presence of an elderly population at risk for ischemia, as there appears to be evidence of some memory loss in mice.
    Journal of Toxicology and Environmental Health Part A 07/2010; 73(17-18):1166-72. DOI:10.1080/15287394.2010.491411 · 1.83 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare effects of four drug combinations on sedation, echocardiographic, haematologic and biochemical variables and recovery in cats. Experimental randomized 'blinded' cross-over study. Six healthy cats. Treatments were administered intramuscularly: midazolam 0.4 mg kg(-1) and butorphanol 0.4 mg kg(-1) (MB); midazolam 0.4 mg kg(-1), butorphanol 0.4 mg kg(-1) and ketamine 3 mg kg(-1) (MBK); midazolam 0.4 mg kg(-1), butorphanol 0.4 mg kg(-1) and dexmedetomidine 5 μg kg(-1) (MBD); ketamine 3 mg kg(-1) and dexmedetomidine 5 μg kg(-1) (KD). Sedation was evaluated at time-points over 10 minutes post injection. Echocardiography, systolic arterial blood pressure (SAP) measurement and blood sampling were performed at baseline and from 10 minutes after treatment. Quality of recovery was scored. Data were analysed by anova for repeated measures. p < 0.05 was considered significant. The lowest sedation score was obtained by MB, (median 10.5 [7; 20]), highest by KD (36.5 [32; 38]). Quality of recovery was best with KD (0.5 [0; 2]), and worst with MB (7.5 [4; 11]). Relative to baseline measurements, treatments decreased SAP by 17%, 25%, 13%, 5% in MB, MBK, MBD and KD, respectively. Heart rate decreased (p < 0.05) after MBD (44%) and KD (34%). All treatments decreased stroke volume by 24%, 21%, 24%, 36%, and cardiac output by 23%, 34%, 54%, 53% in MB, MBK, MBD and KD, respectively. Packed cell volume was decreased (p < 0.05) by 20%, 31%, 29% in MBK, MBD and KD, respectively. Plasma glucose was increased after MBD (31%) and KD (52%) and lactate concentration was decreased (p < 0.05) after MBK (58%), MBD (72%) and KD (65%). The MB combination did not produce sedation in healthy cats. Treatment MBK led to acceptable sedation and minimal cardiovascular changes. Both treatments with dexmedetomidine produced excellent sedation and recovery but induced more cardiovascular depression and haematologic changes.
    Veterinary Anaesthesia and Analgesia 03/2012; 39(2):137-50. DOI:10.1111/j.1467-2995.2011.00699.x · 1.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The effects of xylazine-ketamine administration on arterial blood pressure, arterial blood pH, blood gases, rectal temperature, and heart and respiratory rates were recorded in 5 healthy female goats weighing 17-29 kg. Xylazine (0.2 mg/kg, i.m.) was administered 15 min prior to ketamine (10 mg/kg, i.v.). All baseline measurements were taken before the xylazine administration and were repeated at 5, 15, 30, 45, and 60 min intervals after induction of anaesthesia with ketamine. It was found that heart rate decreased at 15 to 60 min and rectal temperature decreased significantly at 30 to 60 min but respiratory rate did not change significantly. Mean arterial blood pressure declined significantly at 15 to 60 min after anaesthesia. PaO 2 did not change significantly but PaCO 2 values increased significantly at 5, 15, and 60 min. Values of pH decreased significantly at 5 and 15 min. According to this study, xylazine-ketamine combination is responsible for declined arterial blood pressure, bradycardia, increased PaCO 2 , decreased pH and hypothermia in anaesthetized goats.